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Insights into the Mechanistic Basis 
of Plasmid-Mediated Colistin 
Resistance from Crystal Structures 
of the Catalytic Domain of MCR-1
Philip Hinchliffe1, Qiu E. Yang2, Edward Portal2, Tom Young3, Hui Li4, Catherine L. Tooke1, 
Maria J. Carvalho2, Neil G. Paterson5, Jürgen Brem6, Pannika R. Niumsup7, 
Uttapoln Tansawai7, Lei Lei4, Mei Li4, Zhangqi Shen4, Yang Wang4, Christopher J. Schofield6, 
Adrian J Mulholland3, Jianzhong Shen4, Natalie Fey3, Timothy R. Walsh2 & James Spencer1
The polymixin colistin is a “last line” antibiotic against extensively-resistant Gram-negative bacteria. 
Recently, the mcr-1 gene was identified as a plasmid-mediated resistance mechanism in human 
and animal Enterobacteriaceae, with a wide geographical distribution and many producer strains 
resistant to multiple other antibiotics. mcr-1 encodes a membrane-bound enzyme catalysing 
phosphoethanolamine transfer onto bacterial lipid A. Here we present crystal structures revealing 
the MCR-1 periplasmic, catalytic domain to be a zinc metalloprotein with an alkaline phosphatase/
sulphatase fold containing three disulphide bonds. One structure captures a phosphorylated form 
representing the first intermediate in the transfer reaction. Mutation of residues implicated in zinc or 
phosphoethanolamine binding, or catalytic activity, restores colistin susceptibility of recombinant E. 
coli. Zinc deprivation reduces colistin MICs in MCR-1-producing laboratory, environmental, animal and 
human E. coli. Conversely, over-expression of the disulphide isomerase DsbA increases the colistin MIC 
of laboratory E. coli. Preliminary density functional theory calculations on cluster models suggest a 
single zinc ion may be sufficient to support phosphoethanolamine transfer. These data demonstrate 
the importance of zinc and disulphide bonds to MCR-1 activity, suggest that assays under zinc-limiting 
conditions represent a route to phenotypic identification of MCR-1 producing E. coli, and identify key 
features of the likely catalytic mechanism.
Antibiotic resistance, particularly in Gram-negative bacteria (GNB) is a serious and growing global threat. GNB 
constitute a growing proportion of nosocomial infections, contributing to increased morbidity and mortality 
in vulnerable patient groups such as surgery, transplant and chemotherapy patients1. Enterobacteriaceae like 
Escherichia coli and Klebsiella pneumoniae are versatile pathogens causing sepsis, wound, surgical site, respiratory, 
urinary tract and device-associated infections2,3. Treatment of GNB infections is complicated by their intrinsic 
resistance to many antibiotic classes and ready acquisition of resistance to additional agents4. Widespread dis-
semination of plasmids containing multiple resistance determinants has eroded treatment options leaving few 
reliable antibiotics for empiric therapy, a situation exacerbated by the continuing shortage of new antibacterials 
effective against GNB5.
The polymixin colistin is a key therapeutic for GNB infections as the spread of mobile antibiotic resist-
ance increases treatment failure for third generation cephalosporins or carbapenems6. Until recently colistin 
resistance in Enterobacteriaceae was considered uncommon, arising largely from chromosomal mutations in 
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K. pneumoniae strains7. However, recently a plasmid-encoded colistin resistance determinant, MCR-1, was 
identified in an animal-associated E. coli strain, and subsequently found on multi-resistance plasmids from ani-
mal, retail meat and human E. coli and K. pneumoniae8. MCR-1 dissemination, which is already global9, now 
threatens the continuing effectiveness of colistin against GNB infections. In particular, GNB carrying plasmids 
co-expressing MCR-1 and carbapenemases alongside other resistance determinants may be effectively untreatable 
with conventional antibiotics10,11. MCR-1 confers resistance by modifying the colistin target, catalyzing transfer 
of phosphoethanolamine (PEA) onto the glucosamine saccharide of lipid A in the bacterial outer membrane 
(Fig. 1)8. This reduces the net negative charge of the lipid A head group and, consequently, colistin binding12. The 
catalytic mechanism of MCR-1 (and other bacterial PEA-transferases) remains to be established. Here we present 
two crystal structures of the soluble, catalytic domain of MCR-1, revealing this to be a zinc metalloprotein con-
taining three intramolecular disulphide bonds. Colistin susceptibility assays support the proposed importance 
of both zinc and disulphide bond formation to MCR-1 activity, while density functional theory models of key 
states on the proposed reaction pathway indicate that both mono- and di-zinc forms of the enzyme may be able 
to support PEA transfer.
Results
Crystal Structure of MCR-1 Catalytic Domain. Bacterial lipooligosaccharide PEA-transferases such 
as MCR-1 are organised into two domains: an N-terminal inner membrane-bound domain predicted to con-
tain 5 transmembrane α -helices and a soluble, periplasmic domain containing the putative catalytic centre8,13–15. 
Hence, as a first step towards understanding the molecular mechanism of MCR-1 mediated colistin resistance, 
we sought to obtain high-resolution structural information for the MCR-1 catalytic domain. To facilitate such 
studies, we engineered MCR-1 to lack the five transmembrane helices, generating a construct containing resi-
dues 219–541 (MCR1Δ TM) which was purified and crystallised. Phases calculated from datasets collected at 
or near the zinc X-ray absorption edge ultimately yielded structures for two different crystal forms in the space 
groups P41212 (1.75 Å resolution) and P21 (1.55 Å resolution) (Supplementary Table S1). The two structures are 
essentially identical (RMSD 0.37 Å over 311 Cα atoms, Supplementary Figure S1) and reveal an overall α -β -α 
fold, containing three intramolecular disulphide bonds, typical of alkaline phosphatase or sulphatase enzymes, 
with the N-terminus indicating the likely position of the five transmembrane helices (Fig. 2A,B). Both space 
groups contain an identical dimeric form, through interactions between monomers in the asymmetric unit (P21) 
or symmetry-related molecules (P41212) (Supplementary Figure S2). However, size exclusion chromatography 
experiments show MCR1Δ TM is monomeric in solution (Supplementary Figure S2), leading us to conclude that 
this dimeric form is unlikely to be physiologically relevant.
Both structures contain clear electron density for bound metal ion(s) in the putative active site, assigned as 
zinc on the basis of the presence of excess zinc in the purification buffers and a strong signal at the zinc absorp-
tion edge in X-ray fluorescence scans of MCR-1 crystals (Supplementary Figure S3). The consistency with 
DFT-optimised structures (see below) also supports their identification as zinc ions. However, the two crystal 
Figure 1. Phosphoethanolamine Transfer Reaction Catalysed by MCR-1. Panel shows hexa-acylated E. coli 
lipid A structure51 with 1′ and 4′ phosphate groups. MCR-1 catalyses transfer of phosphoethanolamine from a 
phosphatidylethanolamine donor substrate onto lipid A. Figure shows addition of phosphoethanolamine to the 
1′ position of lipid A, consistent with the proposed activity of Salmonella PmrC14.
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forms differ in zinc content, with the P21 structure containing one zinc ion (Zn1), coordinated by Asp465, His466, 
Glu246 and Thr285 in a tetrahedral geometry (Fig. 2C, Supplementary Table S2), while the P41212 structure con-
tains density for an additional, also tetrahedral, zinc site (Zn2) coordinated by His395, His478, a water molecule 
(Wat1) and Glu300 from a symmetry related molecule (Fig. 2D, Supplementary Table S2). Furthermore, the active 
site of the P21 structure contains electron density corresponding to the presence of a phosphate group attached to 
Thr285, the conserved residue believed to act as the acceptor for the PEA group during the transfer reaction13,15. 
This apparent autophosphorylation was confirmed by mass spectrometry of MCR1Δ TM crystallisation samples, 
which showed a mixed population of proteins with a mass difference (78 Da) consistent with the presence of 
phosphorylated and non-phosphorylated forms (Supplementary Figure S4).
The MCR-1 active site occupies a shallow depression on a relatively flat face of the molecule, potentially per-
mitting binding of the relatively large lipid A headgroup in more than one orientation and enabling modification 
at more than one position16. Plots of surface hydrophobicity and charge distributions (Supplementary Figure S5) 
show this region to be both more hydrophobic and less charged than the rest of the protein, consistent with a 
location adjacent to the membrane surface from which the substrates are expected to protrude. In addition to 
Thr285 and the residues that make up the Zn1 site, the active site region contains a number of residues conserved 
between bacterial PEA-transferases8. In particular, in addition to their possible roles as Zn2 ligands (P41212 struc-
ture), in the P21 structure both His395 and His478 are well positioned to interact with phosphorylated Thr285, 
whilst the proximity of Lys333 to Thr285 suggests a possible role for this residue in substrate (PEA) binding. We 
also note the presence of a strong hydrogen bond between ND1 of His478 and OE1 of the conserved Glu468, an 
interaction that could plausibly orient or polarise this histidine as part of a mechanistic role.
Requirements for MCR-1 Activity. The crystallographic results indicate that MCR-1 is a zinc metalloprotein 
containing at least one zinc ion, with both a conserved Thr residue (Thr285) able to autophosphorylate in recombinant 
E. coli and a network of intramolecular disulphide bonds. We therefore sought to test the hypotheses that zinc is 
important to the activity of MCR-1 in the bacterial host, that conserved amino acids participate in zinc/substrate 
binding or in the phospho(ethanolamine) transfer reaction, and that disulphide bond formation in the periplasm 
is important to MCR-1 activity. We evaluated the effects of zinc deprivation, modification of specific amino acids 
(Fig. 3A), or enhanced disulphide bond formation, upon MCR-1 activity in situ as measured by colistin minimal 
inhibitory concentrations (MICs) for mcr-1-positive bacteria. Removal of zinc through inclusion of the chelator 
EDTA in MIC experiments reduced the colistin MICs of laboratory E. coli expressing full-length recombinant 
MCR-1 from 2 μ g/ml to that of vector-only controls (0.25 μ g/ml). Profound reductions in colistin MIC (up to 5 
dilutions) on EDTA exposure were also observed when these experiments were extended to a panel of 68 E. coli 
strains of environmental, animal and human origins (Fig. 3B, Supplementary Figure S6, Supplementary Table S3) 
supporting a requirement for zinc (or possibly other divalent cations) in MCR-1 function. Importantly, EDTA 
treatment had little effect upon the growth or colistin susceptibility of a panel (12 strains including one type 
strain) of mcr-1 negative E. coli collected during the same sampling operations. In the absence of EDTA, these 
negative control samples varied in their colistin susceptiblity (MICs ≤ 0.25 to 1 μ g/ml) up to levels at which sig-
nificant reductions in MIC are easily measurable. However, for these strains increases in colistin susceptibility 
on EDTA treatment were at most one dilution, indicating that EDTA is not affecting membrane permeability to 
colistin, and that MIC reductions in MCR-1-positive strains are rather due to a loss of MCR-1 activity.
Figure 2. Structure of MCR-1 Periplasmic Domain. (A) Organisation of MCR-1 showing 5 predicted 
membrane-spanning α -helices and the soluble periplasmic domain (residues 219–541) crystallised here. 
(B) Overall fold of MCR-1 catalytic domain. Intramolecular disulphide bonds are labeled and metal centre 
(active site) is boxed. (C) Active site of P21 crystal form showing single bound zinc ion (grey sphere) and 
phosphorylation of Thr285. (D) Active site of P41212 crystal form showing dinuclear zinc centre and 
coordination of Zn2 by residue Glu300 (pink) from an adjacent molecule in the crystal lattice.
www.nature.com/scientificreports/
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These results imply that divalent cations, specifically zinc, are important to MCR-1 activity. This inference is 
further supported by the observation that replacement of the zinc ligand Glu246 by alanine reduces the colistin 
MIC of recombinant E. coli to that of vector-only control (Fig. 3C, Supplementary Table S4), an effect equivalent 
to substitution of the acceptor threonine (Thr285). The effects of mutations at other active site residues are how-
ever more variable. Whilst replacement of the conserved His395, part of the Zn2 site (P41212 structure), reduces 
colistin MIC to basal levels, substitutions of the adjacent His478, or its hydrogen-bonding partner Glu468, give 
smaller reductions (3 to 4 dilutions). Similarly, the alanine mutation of Lys333 substantially reduces colistin MIC, 
but not to basal levels. Thus, at positions other than His395, alanine mutants away from the Zn1 site retain some 
ability to protect expressing strains from colistin action. Hence, while important, these residues are not absolutely 
essential to MCR-1 function. Conversely, enhanced disulphide bond formation through overexpression of the 
periplasmic dithiol-disulphide oxidoreductase DsbA has been shown to increase expression and activity of N. 
meningitidis LptA in recombinant E. coli17. We therefore tested whether DsbA co-expression could also increase 
MCR-1 activity, and established that this led to a modest but reproducible increase in the colistin MIC for MCR-
1-expressing E. coli TOP10 (from 4 to 8 μ g/ml). Taken together, these data indicate that zinc, conserved active site 
residues and disulphide bond formation are all important to the structure and activity of MCR-1.
Density Functional Theory Models of MCR-1-catalysed PEA Transfer. Mechanistic proposals 
for phosphoryl transfer by e.g. alkaline phosphatase typically involve two18 or three19 metal ions. Whilst our 
structures unambiguously identify a zinc site (Zn1) in MCR-1 adjacent to the essential Thr285, the Zn2 site 
in the P41212 crystal form involves crystallographic contacts and may not be relevant in solution. This possi-
bility is further supported by another recently released crystal structure of the MCR-1 catalytic domain with 
phospho-Thr285 (PDB 5K4P20) that was crystallised from conditions of high zinc concentration contains zinc 
ions in the Zn1 site and at a number of additional positions, of which none is directly equivalent to the Zn2 site 
identified here. Accordingly, to examine the likely zinc stoichiometry required for PEA transfer, and as a prelim-
inary study of MCR-1 mechanism, we used computational density functional theory (DFT)21,22 to investigate the 
mono- and di-zinc forms of MCR-1, corresponding to the P21 and P41212 crystal structures, respectively, with 
the aim of testing the extent to which each can support the phosphoryl transfer reaction (i.e. addition of PEA to 
Thr285).
DFT calculations were performed on cluster models for the MCR-1 metal centre derived from the two struc-
tures, using simplified models, i.e. substituting [P(O)O(OMe)2]− in the place of the phosphatidylethanolamine 
(substrate 1) and [P(O)(OMe)OO]2− for the lipid A (substrate 2) substrates (procedures are fully described in 
Supplementary Information). Minimum-energy structures could be located for all intermediates along puta-
tive mechanistic pathways requiring either one (Fig. 4A) or two (Supplementary Figure S9A) zinc ions. For the 
mono-zinc mechanism, a model containing Glu246, Thr285, Asp465 and His466, with both Glu246 and Asp465 
deprotonated, provided the best agreement with the experimental crystal structure (Supplementary Table S6). 
The coordination geometry observed about the zinc centre in this model is maintained throughout the postulated 
mechanism (Supplementary Table S7), indicating this to be structurally reasonable. Both Glu246 and Asp465 
are geometrically accessible to act as general bases to activate Thr285, and the intermediates generated by pro-
ton transfer to Glu246 and Asp465 (1Zn-3E, 1Zn-D, Scheme S1, Supplementary Information) were isoenergetic 
Figure 3. Effect of Mutation and Zinc Deprivation upon MCR-1 Activity. (A) MCR-1 active site (P21 crystal 
form) with colours identifying positions of alanine substitutions. (B) Effect of zinc deprivation on colistin 
Minimal Inhibitory Concentrations (MICs) for MCR-1-negative (12 isolates; blue) and MCR-1-expressing  
(68 isolates; red) E. coli. MICs were determined by broth microdilution in the presence and absence of EDTA 
(250 μ g/ml) as described. (C) Colistin MICs (determined by agar dilution, data shown are modes for two 
independent experiments, each performed in duplicate) for alanine substitutions at positions shown in (A).
www.nature.com/scientificreports/
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within the limitations of the computational approach used (Supplementary Table S8), indicating that either res-
idue may activate Thr285.
Similar to the mono-zinc mechanism above, the gas-phase optimised geometries for the di-zinc metal centre 
remain reasonable, and consistent with the crystal structure, around both zinc ions throughout the postulated 
reaction pathway (Supplementary Table S7), confirming that this putative mechanism can be accommodated 
by the crystallographically observed active site. However, unlike the case for the mono-zinc mechanism, acti-
vation of Thr285 by proton transfer to Asp465 resulted in a significant structural change in the active site 
that involves dissociation of this residue from the Zn1 metal ion. In contrast a smaller structural change was 
required for proton transfer to Glu246, and a transition state could be located for reaction of Glu246-activated 
Thr285 with the phosphate diester substrate 1. The relative potential energies (Supplementary Table S10) cal-
culated for the di-zinc mechanism were considerably higher than those obtained for the mono-zinc reaction 
(Supplementary Table S8A), although there was considerable sensitivity to the solvation model and constraints 
used. Nevertheless, these initial calculations indicate that a mono-zinc mechanism for PEA transfer may be feasi-
ble, and demonstrate that the structures presented here can serve as suitable starting points for a more extensive 
computational exploration of MCR-1 mechanism.
Discussion
The initial identification of mcr-1 in an E. coli strain of animal origin in China has prompted extensive analyses of 
new and existing bacterial strain collections that have established this gene to have a wide geographic distribution 
in human, animal and environmental E. coli9. Given this, and the increasing importance of colistin as a last resort 
antibiotic for infections by multiresistant strains of GNB, we have sought to investigate the molecular basis for 
MCR-1 activity as a first step towards understanding its likely impact across the range of GNB and identifying 
possible routes to overcoming its activity. Although full elucidation of the means by which MCR-1 modifies bac-
terial LPS requires structural description of the complete protein, including the membrane-spanning domain, 
the high-resolution structures, and associated microbiological and computational data, that we have been able to 
obtain provide important information that permits some conclusions to be drawn regarding the structural basis 
for MCR-1 activity.
Figure 4. Density Functional Theory (DFT) Modelling of the MCR-1 Active Site (Mono-zinc form).  
(A) Possible mechanism for phosphoethanolamine addition (2) to MCR-1 Thr285 of mono-zinc MCR-1  
(1) to form Thr285 adduct (3). (B) MCR-1 active site crystal structure (P21 form) showing residues used in 
cluster model. (C) DFT-optimised geometry of phosphoethanolamine non-covalently bound to MCR-1 active 
site (2 in panel (A) above). (D) DFT-optimised geometry of MCR-1 active site in the phosphoethanolamine-
bound form (3 in panel (A) above). (See Supplementary Information for full computational details and a 
discussion of results).
www.nature.com/scientificreports/
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Consistent with previously recognised sequence relationships8, structure-based searches23 identify clear 
similarity of both overall fold and active site architecture between MCR-1 and other characterised bacterial 
PEA-transferases (Neisseria meningitidis LptA15 (catalytic domain, PDB 4KAV, 40% sequence identity, RMSD 
1.9 Å over 302 Cα ); Campylobacter jejuni EptC13 (catalytic domain, 4TN0, 41% sequence identity, RMSD 1.5 Å, 
284 Cα )). This relationship further extends to other putative bacterial PEA-transferases as well as sulphatases and 
phosphatases (choline sulphatase (PDB 4UG4, RMSD 2.9, 270 Cα ), arylsulphatase (3ED4, RMSD 3.2, 259 Cα ), 
N-sulphoglucosamine sulphohydrolase24 (4MIV, RMSD 3.0, 262 Cα ) and alkaline phosphatase (2× 98, RMSD 
3.0, 229 Cα )). Thus, like LptA and EptC, MCR-1 can be assigned as a member of the alkaline phosphatase (AP) 
metalloenzyme superfamily. Moreover, both comparisons with previous structures, and our observation of phos-
phorylation in one of our two structures, clearly identify Thr285 as the likely nucleophile and PEA acceptor in 
the catalytic mechanism.
Characterised AP enzymes vary in the nature and number of metal ions required for activity and, conse-
quently, active-site architecture differs substantially between those of known structure25. Our structural com-
parisons identify the ligands to the MCR-1 Zn1 site, Asp465, His466, Glu246 and Thr285, to be well conserved 
between MCR-1, LptA and EptC and between MCR-1 and other AP family members, although the identity of 
the nucleophile differs between enzymes. However, less complete conservation is evident when comparing the 
putative Zn2 sites- while the Zn2 ligands His395 and His478, and the adjacent Glu468, are also well conserved 
between MCR-1, LptA and EptC, these positions vary in less closely related family members such as choline 
sulphatase (Supplementary Figure S7) suggesting that an intact Zn2 site is not a prerequisite for activity in all 
such enzymes. It is also notable that the Zn2 site is not occupied in the structure of EptC, while for LptA Zn2 was 
observed only after exposure to high concentrations of zinc15.
Similarly, a recently released structure of the MCR-1 catalytic domain (PDB 5K4P20, (Supplementary Figure S8), 
crystallised in the presence of 0.2 M ZnS04, contains a total of 10 zinc ions bound to one MCR-1 molecule, includ-
ing 4 in the active site pocket, and differs from the structures presented here specifically at the Zn2 site. While 
the overall folds of both the P21 and P41212 structures are very similar to that of 5K4P (RMSDs 0.286 Å (324 Cα ) 
and 0.432 Å (311 Cα ), respectively), only the Zn1 site is similar in all three structures (Supplementary Figure S8). 
In 5K4P additional zinc ions in the Zn2 site (ZnB, ZnC and ZnD) are coordinated by His395 and the phos-
phate group of phospho-Thr285 (ZnB); by a network of water molecules (ZnC); and His478 and Glu405 
from an adjacent molecule in the crystal lattice (ZnD). In comparison to the phosphorylated P21 structure 
(Supplementary Figure S8) additional zinc binding causes rotation of the Thr285 phosphoryl group and loss of 
interaction of His478 with the phosphoryl-oxygen. This also results in a shift in the position of ZnD in compar-
ison to Zn2 in our MCR 1-P41212 structure (Supplementary Figure S8). These comparisons indicate first that 
the conformations of active site residues in MCR-1 are sensitive to conditions of high zinc content (as in 5K4P), 
demanding caution when making any mechanistic interpretation, and, more importantly, that available structural 
data do not clearly define a unique Zn2 site in MCR-1. Taken together, these data make uncertain the role of this 
metal ion in the PTE transfer reaction. Nevertheless, the effect of alanine substitutions at His395 and His478 on 
colistin susceptibility of producer strains indicates that, irrespective of their role in possible metal binding, both 
of these residues are important to the structure or activity of MCR-1. Similar effects were observed for the equiv-
alent mutations of EptC13. This conclusion is strengthened by the observation that mutation of Glu468, a residue 
positioned to interact with the His478 side chain and whose functional role has to date not been investigated, is 
also deleterious to MCR-1 function.
Notwithstanding the differing metal contents of MCR-1 structures, the presence of zinc in a conserved site 
adjacent to phosphorylated Thr285 provides strong evidence for its importance to MCR-1 function. This conclu-
sion is supported by microbiological experiments in which the effect of the chelator EDTA upon colistin MIC was 
investigated for a collection of E. coli strains. These included samples from hospitalised human patients (China) 
and healthy human volunteers (Thailand); faeces from chickens (China, Thailand) and other farmed and domes-
tic animals (Thailand); and the wider environment (primarily water sources (reservoirs, rivers, canals; Thailand; 
Supplementary Table S3)). For MCR-1-positive strains clear reductions in colistin MIC were observed on EDTA 
treatment, supporting the conclusion that zinc is required for MCR-1 activity in the host. Interpretation of these 
experiments could be complicated by the known effect of chelators such as EDTA upon the Gram-negative outer 
membrane. EDTA treatment sensitises E. coli and other GNB to colistin, as well as a range of antibiotics that fail 
to penetrate Gram-negative cells, most likely due to sequestration of bound magnesium ions that normally hold 
together LPS within the outer membrane26. While we cannot entirely rule out such effects, control experiments 
support the contention that the observed differences in colistin susceptibility relate to loss of MCR-1 activity 
rather than non-specific changes in outer membrane integrity. Specifically for MCR-1 negative E. coli with ele-
vated colistin MICs (0.5 or 1.0 μ g/ml), EDTA reduced these values by at most one dilution, compared to changes 
of up to five dilutions in MCR-1 positive isolates, suggesting that in these strains non-specific effects alone cannot 
account for the observed differences. These results justify further evaluation of this approach as a possible route 
to phenotypic detection of MCR-1 production in E. coli.
AP mechanism has been extensively studied for a number of family members, and, prior to this study, crystal 
structures were available for two known PEA-transferases (LptA and EptC). However, to date the catalytic mech-
anism of these enzymes, or other known PEA-transferases of this family, has been little explored. Accordingly, 
as an initial investigation of the mechanism of PEA transfer, we used DFT to construct a series of models repre-
senting possible states along the PEA transfer pathway catalyzed by MCR-1 in both mono- and di-zinc forms. 
Interestingly, while plausible structural models could be generated for states along both of these pathways, 
energies for species along the mono-zinc pathway were consistently lower than those obtained for the di-zinc 
mechanism. While calculated energies remained sensitive to the model setup (for details see Supplementary 
Information), these data support the hypothesis that a single zinc ion may be sufficient to support at least the first 
stage of the MCR-1 catalysed reaction, i.e. PEA transfer onto Thr285. Importantly, the crystal structures that we 
www.nature.com/scientificreports/
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present here will facilitate the more extensive computational studies required to address this and other mechanis-
tic proposals. In the AP catalysed reaction, the likely role of the second (Zn2) zinc ion is to orient the incoming 
substrate for attack by the nucleophile (MCR-1 Thr285), stabilising the resulting transition state and activating an 
incoming water molecule that degrades the covalent intermediate27. Mono-zinc family members such as phos-
phonate monoester hydrolase (PMH) can fulfil some of these functions by substitution of basic residues for zinc 
in the absence of a second metal site28. Thus, it is plausible that MCR-1 and other LPS PEA-transferases function 
with a single zinc equivalent. However, we cannot rule out the previously raised possibility15 that substrate bind-
ing, particularly of the lipid A acceptor, provides the extra coordination necessary to bind an additional zinc ion 
and that a second metal is required to complete the PEA transfer reaction.
In summary, our data provide near-atomic resolution structures of the MCR-1 catalytic domain that define 
the architecture of the protein and identify key features of its activity. Zinc, disulphide bonds and conserved 
active site residues, including zinc ligands, the acceptor Thr285 and additional positions adjacent to the metal 
centre, are all important to MCR-1 function in E. coli. In particular, investigation of the effect of EDTA on colistin 
susceptibility in producer strains supports this approach as potentially suitable for phenotypic discrimination of 
MCR-1 producing E. coli. DFT calculations indicate that, in contrast to the majority of alkaline phosphatase (AP) 
type enzymes, MCR-1 may require only a single zinc equivalent to catalyse the PEA transfer reaction. These data 
identify MCR-1 (and other related bacterial PEA-transferases) as a distinct subset within the AP enzyme family 
and provide starting points for more extensive investigations of MCR-1 mechanism and inhibition, in particular 
for structure-based design of inhibitors for use in potential colistin-based combination therapies.
Methods
Expression of the MCR-1 catalytic domain. To express the soluble domain of MCR-1 lacking the five 
predicted transmembrane (TM) helices8 (MCR1Δ TM), codons 219–541 were synthesised (Eurofins) and sub-
cloned into the pOPINF29 T7 expression vector with forward and reverse primers (MCR-1soluble F and MCR-1soluble 
R, Supplementary Table S5)). The resultant plasmid, pOPINF-MCR1Δ TM, encodes for N-terminally His6-tagged 
protein cleavable with 3 C protease. E. coli SoluBL21 (DE3) cells (Genlantis) bearing pOPINF-MCR1Δ TM were 
grown at 37 °C in 2xTY media containing 50 μ g ml−1 carbenicillin to A600 0.6, when IPTG was added to a final 
concentration of 0.5 mM, and cell growth continued for 18 h at 18 °C. Cells harvested by centrifugation (6500 × g, 
10 min) were resuspended in 50 mM HEPES pH 7.5, 500 mM NaCl, 2 mM β -mercaptoethanol, 0.1 mM ZnCl2, 
EDTA-free protease inhibitor (Roche), and broken by two 30 000 psi passages through a cell disruptor. All sub-
sequent steps were performed at 4 °C. Unbroken cells were removed by ultracentrifugation at 100,000 × g for 1 h 
and supernatant (plus 10 mM imidazole) incubated 2 h with Ni-NTA resin (Qiagen). Protein-bound resin was 
washed in Buffer A (50 mM HEPES pH 7.5, 400 mM NaCl, 0.1 mM ZnCl2, 1 mM TCEP) plus 10 mM imidazole 
then in Buffer A plus 20 mM imidazole, and protein eluted in 50 mM HEPES pH 7.5, 200 mM NaCl, 10 μ M ZnCl2, 
400 mM imidazole, 1 mM TCEP. Imidazole was reduced to 10 mM in an Amicon 10-kDa centrifugal filter. The tag 
was removed by 3 C protease cleavage overnight and capture on Ni-NTA resin. Protein was subsequently loaded 
onto a Superdex 75 column equilibrated in 50 mM HEPES pH 7.5, 150 mM NaCl, 100 μ M ZnCl2. Peak fractions 
were concentrated to 16 mg/mL.
Crystallisation, Structure determination and Analysis. The MCR-1 soluble domain was crystallised 
by sitting drop vapour diffusion at 18 °C in MRC 96-well crystallisation plates (Molecular Dimensions). P41212 
crystals formed by mixing 400 nL protein with 200 nL crystallisation reagent [0.1 M MOPS/HEPES-Na pH 7.5, 
10% w/v PEG 20000, 20% v/v PEG MME 550, 0.02 M 1,6-hexanediol, 0.02 M 1-butanol, 0.02 M 1,2-propanediol, 
0.02 M 2-propanol, 0.02 M 1,4-butanediol, 0.02 M 1,3-propanediol]. P21 crystals formed by mixing 300 nL protein 
with 600 nL crystallisation reagent (0.2 M Lithium chloride, 0.1 M sodium acetate pH 5.0, 20% w/v PEG6000). 
Drops were equilibrated against 50 μ l crystallisation reagent. Crystals grew to maximum size in 14 days. For freez-
ing, crystals were transferred into cryoprotectant (reservoir solution plus 20% glycerol) before harvesting with a 
cryo-loop and flash-freezing in liquid nitrogen.
Diffraction data were collected at 100 K on beamlines I03 (Zn-edge datasets) and I04–1 or I02 (native data-
sets) at Diamond Light Source, UK. An X-ray fluorescence scan around the Zn-edge (9626 to 9685 eV) clearly 
showed a peak corresponding to the presence of zinc in the crystal. The structure was therefore determined using 
the Single-wavelength Anomalous Dispersion (SAD) method by combining four 2.5 Å resolution isomorphous 
datasets collected at the Zn-edge (wavelengths in Table S1). The datasets were indexed and integrated using XDS30 
and combined and scaled using Aimless31 in CCP432. Experimental phases, a density modified map and an initial 
model were calculated using AutoSol33 in Phenix34, with one molecule in the asymmetric unit and two zinc sites 
identified. Figure of merits were 0.31 and 0.66, before and after density modification. The model was further built 
using AutoBuild35 in Phenix. This initial structure was then used as a search model for molecular replacement 
with Phaser36 to phase a 1.75 Å resolution P41212 dataset indexed and integrated using DIALS, as implemented 
in Xia237, and scaled and merged in Aimless. The 1.55 Å resolution P21 native dataset was processed using the 
Xia2 pipeline (indexed and integrated using XDS and scaled using Aimless). Phases were calculated by molec-
ular replacement with Phaser, using the P41212 structure as a starting model. Structures were completed in both 
cases by iterative rounds of manual model building in Coot38 and refinement in Phenix. Structure validation was 
assisted by Molprobity39 and Phenix.
Co-ordinates and structure factors have been deposited with the Protein Data Bank (www.rcsb.org/pdb) with 
accession numbers 5LRM and 5LRN.
Analytical Size Exclusion Chromatography. Purified protein used for crystallographic studies was analysed 
by size exclusion chromatography. Protein was loaded on to a Superdex 75 column equilibrated in 50 mM HEPES 
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pH 7.5, 150 mM NaCl, 100 μ M ZnCl2. Elution volume was compared against the elution volume of standards (GE 
Healthcare) to determine molecular weight. Column void volume was determined by loading blue dextran 2000.
Mass Spectrometry of Purified Recombinant MCR-1. Mass spectrometry measurements were carried 
out as previously described40. Briefly, electrospray ionization (ESI) -spectra were acquired in the positive ion 
mode using a Waters LCT Premier instrument equipped with a TOF analyser. An LCT Premier mass spectrom-
eter (Waters) was coupled to an Agilent 1100 Series HPLC using a Chromolith® FastGradient RP-18 endcapped 
column equipped with a 50-2 HPLC column, made of monolithic silica (C18, 2 × 50 mm, macropores with 1.6 μ m 
diameter, Merck). The instrument was connected to a CTC-autosampler inlet system. A multi-step gradient over 
10 min was run (solvent A 94.9% H2O/5% CH3CN/0.1% formic acid, solvent B 99.9% CH3CN/0.1% formic acid; 
0-1 min 5% B for equilibration, followed by a linear gradient to 100% B over 4 min, then 100% B for an addi-
tional 3 min, followed by a linear gradient over 2 min back to 5% B to re-equilibrate the column) to separate the 
protein samples at flow rates of 0.4 ml/min for the first 5 min and then 1.0 ml/min for the remaining time. The 
electrospray ionisation source used a capillary voltage of 3.2 kV and cone voltage of 25 V. Nitrogen was used as 
the nebuliser and desolvation gas at a flow rate of 600 l/h. Protein typically eluted as a peak between 3 and 5 min 
under these conditions. Calculated masses were obtained using the ExPasy ProtParam tool (http://web.expasy.
org/protparam/).
Construction of MCR-1-expressing Plasmid for Susceptibility Testing. Susceptibility testing was 
carried out on full-length MCR-1 constitutively expressed from the pUC19 vector41. The mcr-1 coding region 
with its own promoter (156 bp) and downstream sequence (111 bp) was PCR amplified from plasmid pHN-
SHP458 using Q5 High-Fidelity DNA Polymerase (New England Biolabs) and mcr-1 1893 F and mcr-1-1893 R 
(Supplementary Table S5). The fragment was phosphorylated, gel purified, digested with XbaI and EcoRI and 
cloned into XbaI and EcoRI-digested pUC19 to create plasmid pUC19-mcr-1. The integrity of the construct was 
confirmed by DNA sequencing.
Construction of MCR-1 Site-Directed Mutants. MCR-1 mutants were generated in pUC19-mcr-1 using 
the QuikChange II XL Site-Directed mutagenesis kit (Agilent Genomics) with a modified protocol (reaction 
cycles increased to 21) and primers as specified in Supplementary Table S5.
Co-expression of MCR-1 and E. coli DsbA. The mcr-1 containing fragment was excised from plasmid 
pUC-19-mcr-1 by double digestion with EcoRI and XbaI and ligated into plasmid pSU1842 to generate plasmid 
pSU18-mcr-1. pSU18-mcr-1 was transformed into E. coli TOP10 (Invitrogen), purified and its integrity verified 
by double restriction digestion and DNA sequencing. A 627 bp fragment corresponding to the dsbA open read-
ing frame from E.coli MG1655 (NCBI reference sequence: NC_00913.3) was synthesised (Thermo-Fisher). The 
fragment was inserted into pBAD-HisA (Invitrogen) using the HindIII and NcoI restriction sites to create plas-
mid pBAD-dsbA which was transformed into E. coli TOP10 (Invitrogen). pBAD-dsbA was purified from trans-
formants and its integrity verified by double restriction digestion and DNA sequencing. Plasmids pSU18-mcr-1 
and pBAD-dsbA were transformed into E. coli TOP10 and recombinants selected on LB agar plates containing 
chloramphenicol (25 mg/L) and ampicillin (100 mg/L). The plasmid complement of transformants was verified 
by PCR and double restriction digestion. Cells containing plasmids pSU18-mcr-1 and pBAD-dsbA were tested 
for colistin susceptibility by agar dilution as described below.
Antimicrobial susceptibility Testing. Agar Dilution Method. Minimal inhibitory concentrations 
(MICs) of colistin for E. coli TOP10 cells expressing wild-type MCR-1 and mutants in pUC19, and co-expressing 
MCR-1 and E. coli DsbA, were assayed by the agar dilution method, according to the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST). Briefly, bacterial suspensions of optical density corresponding 
to a 0.5 McFarland Standard (approximately 1.5 × 108 CFU/mL) were prepared for the tests and used to inocu-
late Mueller-Hinton (Becton Dickinson, USA) agar plates supplemented with colistin at concentration ranges of 
0.125–128 mg/L. E.coli strain ATCC 25922 was used for quality control purposes. Two independent experiments, 
each with samples in duplicate, were carried out.
Broth Microdilution Method. The effect of EDTA upon the colistin susceptibility of laboratory, environmental, 
veterinary and clinical E. coli isolates was assessed by broth microdilution according to the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST). Details of bacterial strains used in these experiments are 
given in Table S3. Briefly, cells were resuspended to an optical density corresponding to a 0.5 McFarland standard 
(approximately 1.5 × 108 CFU/mL) and used to inoculate 96-well microtitre plates containing cation-adjusted 
Mueller-Hinton medium (Becton Dickinson, USA) at colistin concentrations from 0.25 to 128 μ g/mL. EDTA was 
added to experimental wells to a final concentration of 250 μ g/ml EDTA. Plates were incubated overnight at 37 °C 
and optical density read on a plate reader at 492 nm. Experiments were carried out in duplicate; for strains isolated 
in China (Table S3) the experiment was repeated three times.
Density Functional Theory Calculations. Starting geometries were generated from X-ray crystal struc-
tures by inclusion of residues within approximately 5–10 Å of the zinc ions, and subsequent manual reduction 
to include relevant residue side chains and loops. Residues were truncated at an alpha carbon and saturated with 
hydrogen atoms; hydrogen atoms were also added manually to satisfy the valencies of all other atoms in the 
model. Optimisations were performed using six cartesian constraints on alpha carbons for intermediates in which 
His395 and His478 were included and four where they were excluded. All optimisations were performed using 
Jaguar version 8.543, with the B3LYP hybrid functional44–47 using loose convergence criteria. Test calculations 
on other complexes using the more stringent default convergence criteria did not lead to significant changes in 
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energies, bond lengths, or angles, but were much more time-consuming. A relativistic effective core potential was 
used for the zinc atom(s) as incorporated into Jaguar’s LACV3P* basis set, and the Pople 6–31 G* basis set for 
all other atoms. Energies were calculated using single point calculations incorporating the Poisson–Boltzmann 
finite-element model of solvation48,49 as implemented in Jaguar. The dielectric constant was set to 4, as commonly 
used in the cluster model approach50 and the probe radius to 2 Å. Vibrational frequencies were not computed, 
and so the energetic data do not include a correction for zero-point energy, although we note that this would be 
expected to be quite small. In the absence of frequency calculations, stationary points have not been verified as 
minima.
Code Availability. Jaguar version 8.5 is available from Schrodinger, Inc., New York, NY. See https://www.schro-
dinger.com/jaguar for details.
Data Access Statement. Crystal structures are available from the Protein Data Bank (www.rcsb.org/pdb) 
with accession numbers 5LRM and 5LRN. All other data supporting this study are provided as Supplementary 
Information accompanying this paper.
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